Comparison of the safety and effectiveness of local spray stem cells conditioned medium and erbium laser compared to triamcinolone and erbium laser in the treatment of hand eczema

Comparison of the safety and effectiveness of Wharton jelly mesenchymal stem cell condition medium spray and erbium laser with triamcinolone and erbium laser in the treatment of resistant hand eczema

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

IRCT

Registry ID

IRCT20200127046282N26

Enrollment

Registered

2023-04-21

Start date

2023-05-05

Completion date

Unknown

Last updated

2023-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hand eczema. Diseases of the skin and subcutaneous tissue

Interventions

Intervention 1: Intervention group: 10 patients are subjected to local spray of Wharton's jelly mesenchymal stem cell conditioned medium and erbium laser 3 times with an interval of 1 month. Intervent

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Healthy patients with hand eczema who have not used any topical medication in the past 2 weeks or any systemic medication in the past month.

Exclusion criteria

Exclusion criteria: Pregnancy Breastfeeding Severe sensitivity to the study drug

Design outcomes

Primary

Measure	Time frame
Reduce or improve hand eczema. Timepoint: before and two weeks after the end of the study. Method of measurement: Using Eczema Extent and Severity Scale (EASI).	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSona Zare

Skin and Stem cell Research Center of Tehran University of Medical Sciences

sonazarebio@gmail.com+98 21 2665 7438

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026